Physician profile
Chad E Coleman
NPI 1194768358
$1,299.96
in general payments reported to CMS, 2019-2025
26 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $469 · 2020: $47.15 · 2021: $61.48 · 2022: $203 · 2023: $122 · 2024: $277 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $249.96 | 2019-2025 | Ozempic, Rybelsus |
| Fisher & Paykel Healthcare INC | $239.27 | 2024-2025 | Fisher & Paykel Healthcare |
| Pfizer INC. | $106.23 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $94.23 | 2019-2024 | Airsupra |
| Lilly USA, LLC | $93.47 | 2019-2022 | |
| Exact Sciences Corporation | $61.85 | 2024-2025 | Cologuard Collection Kit |
| Abbvie INC. | $54.09 | 2021-2023 | Ubrelvy |
| Amgen INC. | $49.79 | 2019 | |
| Tolmar, INC. | $36.57 | 2025 | Jatenzo |
| Glaxosmithkline, LLC. | $33.34 | 2022-2025 | Nucala |
| Lundbeck LLC | $32.61 | 2022 | |
| Janssen Pharmaceuticals, INC | $24.86 | 2019 | |
| Astellas Pharma US INC | $21.29 | 2023 | Veozah |
| Upsher-Smith Laboratories LLC | $20.28 | 2019 | |
| Shire North American Group INC | $19.42 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $19.25 | 2019 | |
| Allergan, INC. | $18.76 | 2019 | |
| Aytu Biopharma, INC. | $15.99 | 2019 | |
| Idorsia Pharmaceuticals US INC | $14.96 | 2023 | Quviviq |
| Sunovion Pharmaceuticals INC. | $14.58 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.35 | 2019 | |
| Intuity Medical INC | $13.53 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Adlon Therapeutics L.P. | $13.28 | 2019 | |
| Merck Sharp & Dohme LLC | $13.03 | 2019 | |
| Sanofi Pasteur INC. | $12.82 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Coleman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.